EyePoint Pharmaceuticals, Inc.EYPTNASDAQ
LOADING
|||
Switch Symbol:
Gross Profit Over Time
Above historical average, strong compound growth.
Left:
||||
Revenue minus cost of goods sold
Latest
$39.56M
↑ 104% above average
Average (9y)
$19.41M
Historical baseline
Range
High:$41.39M
Low:$-15.54M
CAGR
+14.0%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $39.56M | -4.4% |
| 2023 | $41.39M | +25.1% |
| 2022 | $33.08M | +15.0% |
| 2021 | $28.76M | +0.5% |
| 2020 | $28.61M | +61.9% |
| 2019 | $17.68M | +213.8% |
| 2018 | $-15.54M | -306.1% |
| 2017 | $7.54M | +836.5% |
| 2016 | $805000.00 | -93.4% |
| 2015 | $12.18M | - |